Search Results - "Lanigan, Fiona T."

Master Transcriptional Regulators in Cancer: Discovery via Reverse Engineering Approaches and Subsequent Validation by Moran, Bruce, Rahman, Arman, Palonen, Katja, Lanigan, Fiona T, Gallagher, William M

“…Reverse engineering of transcriptional networks using gene expression data enables identification of genes that underpin the development and progression of…”
Get full text

Prognostic value of the 6-gene OncoMasTR test in hormone receptor–positive HER2-negative early-stage breast cancer: Comparative analysis with standard clinicopathological factors by Lynch, Seodhna M., Russell, Niamh M., Barron, Stephen, Wang, Chan-Ju A., Loughman, Tony, Dynoodt, Peter, Fender, Bozena, Lopez-Ruiz, Cesar, O'Grady, Anthony, Sheehan, Katherine M., Fay, Joanna, Amberger-Murphy, Verena, Saha, Anurati, Klinger, Rut, Gonzalez, Claudia A., Al-Attar, Nebras, Rahman, Arman, O'Leary, Desmond, Lanigan, Fiona T., Bracken, Adrian P., Crown, John, Kelly, Catherine M., O'Connor, Darran P., Gallagher, William M.

“…The aim of the study was to assess the prognostic performance of a 6-gene molecular score (OncoMasTR Molecular Score [OMm]) and a composite risk score…”
Get full text

High levels of proliferation regulators and an impaired senescence response pathway to identify early-stage breast tumors with a poor prognosis by Lanigan, Fiona T., Dunne, Eiseart J., Brien, Gerard L., Al Oraifi, Fatima, Fan, Yue, Quinn, Cecily, Flanagan, Louise, Fridberg, Marie, Jirstrom, Karin, Geraghty, James G., Gallagher, William M., Bracken, Adrian P.

“…Abstract only 43 Background: Predicting the risk of tumour recurrence, and thus the need for chemotherapy, for lymph node-negative breast cancer patients is a…”
Get full text